Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 2Completed 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 6Interventional 2

Sponsor

Conditions

Breast Neoplasms 4997Neoplasms 4192Prostatic Neoplasms 2426Carcinoma, Non-Small-Cell Lung 2261Colorectal Neoplasms 2050Lung Neoplasms 1703Multiple Myeloma 1454Lymphoma 1403Leukemia, Myeloid, Acute 1379Neoplasm Metastasis 1372Melanoma 1269Pancreatic Neoplasms 1200Leukemia 1194Ovarian Neoplasms 1190Lymphoma, Non-Hodgkin 1128Precursor Cell Lymphoblastic Leukemia-Lymphoma 1088Head and Neck Neoplasms 1055Leukemia, Lymphocytic, Chronic, B-Cell 994Lymphoma, Follicular 896Colonic Neoplasms 893Brain Neoplasms 875Stomach Neoplasms 854Recurrence 848Carcinoma, Hepatocellular 845Glioblastoma 837Lymphoma, Large B-Cell, Diffuse 770Rectal Neoplasms 758Uterine Cervical Neoplasms 725Carcinoma, Renal Cell 704Hodgkin Disease 696

Interventions

Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Li-Fraumeni Syndrome × Clear all
NCT01464086 2021-02-25

LIFSCREEN

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
107 enrolled

Li-Fraumeni Syndrome

NCT01981525 2020-12-14

A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
26 enrolled

Li-Fraumeni Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡